Peripheral Embolization Coils Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Peripheral Embolization Coils Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Detachable Coil and Pushable Coil), Material (Platinum, Platinum and Hydrogel, and Platinum Tungsten Alloy), Application (Bleeding and Trauma, Malformations, Tumors, Visceral Aneurysm, Endoleak Type II, and Varicose Veins), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00039170
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 142
Buy Now

The peripheral embolization coils market size is projected to reach US$ 613.96 million by 2031 from US$ 433.06 million in 2023. The market is expected to register a CAGR of 4.5% during 2023–2031. The growing importance of packing density is likely to remain a key trend in the peripheral embolization coils market.

Peripheral Embolization Coils Market Analysis

A rise in the prevalence of aortic aneurysms and an increase in the incidence of cancer are the key factors driving the peripheral embolization coils market. New product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Overview

Embolization procedures have become an integral part of interventional radiology treatments. A peripheral coil embolization system is used to treat vascular illnesses such as bleeding and trauma, aneurysms [arteriovenous malformations (AVMs)], tumors, and others. The platinum coil peripheral embolization system is most commonly used to treat extracerebral aneurysms and internal carotid aneurysms. An extracerebral aneurysm is a hemangioma that develops in one of the extracerebral arteries, such as the carotid or skull base artery. It is a common vascular abnormality that is prone to rupture, resulting in catastrophic complications such as stroke and hemorrhage.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Peripheral Embolization Coils Market: Strategic Insights

Peripheral Embolization Coils Market

  • CAGR (2023 - 2031)
    4.5%
  • Market Size 2023
    US$ 433.06 Million
  • Market Size 2031
    US$ 613.96 Million

Market Dynamics

GROWTH DRIVERS
  • Rise in Prevalence of Aortic Aneurysm
FUTURE TRENDS
  • Increase in Incidence of Cancer
OPPORTUNITIES
  • Expanding Range of Applications of Embolization Coils

Key Players

  • Medtronic Plc,
  • Penumbra Inc.,
  • Balt,
  • Boston Scientific Corp,
  • Cook Medical Holdings LLC,
  • Wallaby Medical,
  • Spartan Micro Inc.,
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD.,
  • Terumo Corp,
  • NeuroSafe Medical Co. Ltd.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Detachable Coil
  • Pushable Coil
Material
  • Platinum
  • Platinum and Hydrogel
  • Platinum Tungsten Alloy
Application
  • Bleedings and Trauma
  • Malformations
  • Tumours
  • Visceral Aneurysm
  • Endoleak Type II
  • Varicose Veins
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Peripheral Embolization Coils Market Drivers and Opportunities

Increase in Incidence of Cancer Favors Market Growth

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Expanding Range of Applications of Embolization Coils to Create Notable Opportunities in Future

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approvals, which help them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below.

In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy.

Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Report Segmentation Analysis

Key segments that contributed to the derivation of the peripheral embolization coils market analysis are type, material, and application.

  • By type, the market is bifurcated into pushable coil and detachable coil. In 2023, the detachable coil segment held a larger share of the market.
  • Based on material, the peripheral embolization coils market is segmented into platinum, platinum and hydrogel, and platinum tungsten alloy. In 2023, the platinum segment held the largest share of the market and is estimated to register the highest CAGR during the forecast period.
  • By application, the market is divided into bleeding and trauma, malformations, tumors, visceral aneurysms, endoleak type II, and varicose veins. In 2023, the bleeding and trauma segment held the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period.

Peripheral Embolization Coils Market Share Analysis by Geography

The geographic scope of the peripheral embolization coils market report encompasses five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Europe dominated the peripheral embolization coils market in 2023. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation.

Peripheral Embolization Coils Market Report Scope

Report Attribute Details
Market size in 2023 US$ 433.06 Million
Market Size by 2031 US$ 613.96 Million
Global CAGR (2023 - 2031) 4.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Detachable Coil
  • Pushable Coil
By Material
  • Platinum
  • Platinum and Hydrogel
  • Platinum Tungsten Alloy
By Application
  • Bleedings and Trauma
  • Malformations
  • Tumours
  • Visceral Aneurysm
  • Endoleak Type II
  • Varicose Veins
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic Plc,
  • Penumbra Inc.,
  • Balt,
  • Boston Scientific Corp,
  • Cook Medical Holdings LLC,
  • Wallaby Medical,
  • Spartan Micro Inc.,
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD.,
  • Terumo Corp,
  • NeuroSafe Medical Co. Ltd.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Peripheral Embolization Coils Market News and Recent Developments

    The peripheral embolization coils market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are mentioned below:

    • Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval for its ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System from the National Medical Products Administration (NMPA). ZYLOX Phoenix is a proprietary medical device independently developed by the company for the minimally invasive interventional treatment of peripheral arterial embolism. (ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD., Press Release, January 2024)
    • Boston Scientific Corporation received US Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. (Coloplast Group, Press Release, April 2022)
    • Wallaby Medical announced the acquisition of phenox GmbH—including femtos GmbH (femtos), a Germany-based global innovation and technology leader in the neurovascular space. The acquisition has been one of the world’s largest cross-border transactions in the medical device industry in recent years. It would enable the combined company to leverage the broad geographic coverage and product portfolio of participant companies to become a global leader in providing a wide range of neurovascular technologies and solutions to its customers and patients in the US, China, Europe, Japan, and other international markets. (Wallaby Medical, Press Release, April 2022)
    • Wallaby Medical Holding, Inc. received approval from the National Medical Products Administration (NMPA) to market its Avenir Plus Coil System in China. The product was developed independently by Wallaby with the objective of safely and efficiently achieving a dense packing of aneurysms, isolating them from blood flow, and lowering the risk of future rupture or re-rupture. Smaller, softer coils included in the new Avenir Plus Coil System assist physicians in achieving such dense packing. (Wallaby Medical, Press Release, April 2022)

    Peripheral Embolization Coils Market Report Coverage and Deliverables

    The “Peripheral Embolization Coils Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    • Peripheral embolization coils market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Peripheral embolization coils market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Peripheral embolization coils market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral embolization coils market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What would be the expected CAGR of the peripheral embolization coils market?

    The market is estimated to record a CAGR of 4.5% during 2023–2031.

    What would be the estimated value of the peripheral embolization coils market by 2031?

    The estimated value of the market by 2031 will be US$ 613.96 million.

    What would be a prominent future trend in the peripheral embolization coils market?

    The growing focus on packing density is likely to emerge as a significant trend in the market in the future.

    Which are the leading players operating in the peripheral embolization coils market?

    Medtronic Plc, Penumbra Inc., Balt, Boston Scientific Corp, Cook Medical Holdings LLC, Wallaby Medical, Spartan Micro Inc., Zylox-Tonbridge Medical Technology Co Ltd., Terumo Corp, and NeuroSafe Medical Co. Ltd. are the leading players operating in the peripheral embolization coils market.

    What are the factors driving the peripheral embolization coils market growth?

    A rise in the prevalence of aortic aneurysms and an increase in the incidence of cancer are the major factors bolstering the market.

    The List of Companies - Peripheral Embolization Coils Market

    1. Sonic Healthcare Ltd
    2. UNILABS
    3. Laboratory Corp of America Holdings
    4. Quest Diagnostics Inc
    5. ARUP Laboratories Inc
    6. Clinical Reference Laboratory Inc
    7. SYNLAB International GmbH
    8. Myraid Genetics Inc
    9. Boca Biolistics LLC
    10. TOPLAB

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Peripheral Embolization Coils Market


    -->